BioSpace News Archive

Business

Intuitive Announces First Quarter 2023 Earnings

Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced financial results for the quarter ended March 31, 2023.

April 18, 2023

·

20 min read

Business

Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women’s Hospital and Updates to University of Minnesota License Agreement

Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH) today announced that it has entered into a clinical trial agreement with Brigham and Women’s Hospital for the evaluation of CP101, a Complete Consortia microbiome therapeutic, in ulcerative colitis.

April 18, 2023

·

5 min read

Lone Star Bio

Plus Therapeutics to Participate in Panel at the Canaccord Genuity Horizons in Oncology Virtual Conference

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) announced today that Norman LaFrance, M.D., Chief Medical Officer and Senior Vice President, will participate as a panel presenter at the Canaccord Genuity Horizons in Oncology Virtual Conference.

April 18, 2023

·

4 min read

Business

Silk Road Medical to Report First Quarter 2023 Financial Results on May 9, 2023

Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced it will report financial results for the first quarter 2023 after market close on Tuesday, May 9th, 2023.

April 18, 2023

·

1 min read

Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

Medexus Pharmaceuticals is pleased to announce that company management will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference from April 25 to 26, 2023.

April 18, 2023

·

3 min read

Satellos Bioscience Inc. Announces Public Offering of Common Shares

Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Company”), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated

April 18, 2023

·

8 min read

Agilis Robotics conducts first live animal trial for GI indication, targeting 510(k) clearance by 2025 to transform endoscopic surgery

Agilis Robotics, an innovative spin-off company from The University of Hong Kong, is making waves in the realm of endoscopic surgery with its flexible robotic arms.

April 18, 2023

·

2 min read

Drug Development

Bridge Biotherapeutics Releases Updated Preclinical Data for BBT-207 at the AACR Annual Meeting

Bridge Biotherapeutics presented a poster with preclinical data updates of its drug candidate BBT-207 at the American Association for Cancer Research 2023 annual meeting, being held from April 14 to 19 in Orlando, Florida.

April 18, 2023

·

5 min read

Genetown

Gamida Cell Announces Launch of Public Offering of Securities - April 19, 2023

Gamida Cell Ltd. announced the launch of a follow-on public offering of its ordinary shares and accompanying warrants to purchase its ordinary shares.

April 18, 2023

·

3 min read

Drug Development

Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use

Cali Biosciences Co., Ltd. announced it has initiated Phase III studies of its core product, CPL-01, with dosing in hernia patients already begun and dosing in bunion patients scheduled to start next month.

April 18, 2023

·

3 min read